Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 — Indianapolis, Indiana

Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 is a clinical research site located in Indianapolis, Indiana, United States 46202-5112.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 has participated in 1 clinical trials.

Therapeutic areas: Chronic Graft Versus Host Disease.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010?

Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 conducted?

Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 has 1 clinical trials on record. Their work covers Chronic Graft Versus Host Disease.

Is Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 accredited by Crixeo Clinical Trials?

Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.